What Happened?
Bethlehem, PA-based OraSure Appointed Scott Gleason as Interim Chief Financial Officer and Senior Vice President of Investor Relations and Corporate Communications
About the Company
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure`s portfolio of products is sold globally to clinical laboratories, hospitals, physician`s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers.
About the Person
Scott Gleason is Interim Chief Financial Officer and Senior Vice President of Investor Relations and Corporate Communications at OraSure. Previously, Scott held various senior HR leadership roles in the industry.
Info Source
News
Short Profile